inVentiv Health Establishes Operation In Korea
inVentiv Health, Inc., offering best-in-class clinical, commercial and consulting services to the healthcare industry, recently announced that it has established inVentiv Health Korea, a Seoul-based operation that will provide clinical development and commercial services to healthcare clients.
inVentiv Health Korea will deliver outsourced sales services through the company's Selling Solutions segment. inVentiv has recently signed an agreement with a top-20, multi-national pharmaceutical company to provide medical representatives to promote several of its products in Korea. In addition, inVentiv Health Korea is already providing clinical development services to several pharmaceutical clients through its clinical segment, PharmaNet/i3.
"Our clients are expanding their businesses in Asia and as they do, inVentiv is broadening its geographic reach to meet their outsourcing needs," said Paul Meister, CEO of inVentiv Health Inc. "As a $15B pharmaceutical market expected to grow by significant margins over the next several years, Korea is an attractive opportunity for us. Not only are our pharmaceutical clients increasingly conducting clinical research in Korea, it is also a market where many leading pharmaceutical brands in the U.S. will be launching in the coming years, creating a growing need for outsourced sales and marketing support. Our move into Korea also reflects our commitment to expanding inVentiv's best-in-class services into key emerging markets."
inVentiv Health Korea will be led by Jae-Hee Kim, who will serve as President. Mr. Kim has more than 20 years of executive leadership, new business development, client services, and sales and marketing experience. Prior to his current position, Mr. Kim was a Representative Director at Enters Partners Co. Ltd., a marketing and consulting company to the pharmaceutical industry. He has held several senior-level positions with Korean Green Cross Corporation, SmithKline Beecham, and Quintiles Transnational. Mr. Kim graduated from the Department of Business Administration, Chung-Ang University and received his Executive MBA from the Helsinki School of Economics.
"Jae-Hee Kim brings a great depth of experience to this role having held senior roles at top pharmaceutical manufacturing companies and within leading service-side healthcare businesses. With unmatched knowledge of the Korean marketplace, Mr. Kim is the ideal candidate to help inVentiv establish a strong presence in this important geography," said Rick Finnegan, Executive Vice President, Global Operations, inVentiv Health.
About inVentiv Health
inVentiv Health, Inc. is a leading global provider of best-in-class clinical, commercial and consulting services to companies seeking to accelerate performance. inVentiv's client roster includes more than 550 pharmaceutical, biotech and life sciences companies. With 13,000 employees in 40 countries, inVentiv rapidly transforms promising ideas into commercial reality. inVentiv Health Inc. is privately owned by inVentiv Group Holdings Inc., an organization sponsored by affiliates of Thomas H. Lee Partners, L.P., Liberty Lane Partners and members of the inVentiv management team. For more information, visit http://www.inventivhealth.com.
SOURCE: inVentiv Health